Primary information |
---|
sequence ID | Seq_7594 |
Peptide sequence | SRSGGGGGGGLGSGGSIRSSY |
CancerPDF_ID | CancerPDF_ID8600, CancerPDF_ID9824, |
PMID | 23667664,21533267 |
Protein Name | Cytokeratin,"Keratin, type I cytoskeletal 9" |
UniprotKB Entry Name | KRT1_HUMAN,K1C9_HUMAN |
Fluid | Serum,Serum |
M/Z | 1811.85,604.96 |
Charge | 1,3 |
Mass (in Da) | 1813.88,NA |
fdr | NA,NA |
Profiling Technique | MALDI-TOF,LC-MS |
Peptide Identification technique | FT-ICR MS/MS + nano-HPLC,LC/MS/MS |
Quantification Technique | NA,Multiple Reaction Monitoring |
Labelled/Label Free | Label Free,Label Free |
FDR | NA,1.49 |
CancerPDF_ID | CancerPDF_ID8600, CancerPDF_ID9824, |
p-Value | NA,NA |
Software | MASCOT,MASCOT |
Length | 21,21 |
Cancer Type | "Breast cancer, Lung cancer, Rectal cancer",Lung adenocarcinoma |
Database | NA,Swissprot Database (57.4) |
Modification | NA,NA |
Number of Patients | "Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy",62 lung adenocarcinoma and 30 healthy control |
Regulation | NA,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" |
Validation | NA,MRM-based validation of 19 candidates |
Sensitivity | NA,NA |
Specificity | NA,NA |
Accuracy | NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | 240526
|